Established and emerging roles of lysosomal dysfunction in cardiac aging.
Abstract
Cardiac aging is a central biological process underlying most cardiovascular diseases. Lysosomes, once regarded as terminal degradative compartments, are now recognized as dynamic metabolic and signaling hubs whose dysfunction has profound consequences for the aging heart. Human lysosomal storage disorders provide compelling evidence that isolated lysosomal defects are sufficient to cause early cardiomyopathy, underscoring the myocardium's exceptional dependence on sustained lysosomal competence. In physiological aging, impaired autophagy is the most apparent manifestation of lysosomal decline but represents only one facet of a broader network regulating nutrient sensing, ion and lipid homeostasis, receptor trafficking, exocytosis/secretion and inter-organelle communication. Here, we review established and emerging lysosome-dependent mechanisms across the hallmarks of cardiac aging, highlighting lysosomes as potential upstream drivers of this process. We discuss key knowledge gaps and therapeutic strategies aimed at restoring lysosomal function, positioning lysosomes as central and actionable targets for preserving cardiac resilience with age.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
This review proposes that lysosomal dysfunction is a central, upstream driver of cardiac aging and a potential therapeutic target for preserving cardiac resilience. The paper is relevant because it addresses a fundamental biological mechanism of aging (lysosomal decline) rather than just treating symptoms, but as a review article summarizing established knowledge with incremental insights into specific cardiac mechanisms, its scientific impact is minor.
Author of this paper? Send a correction.